US Patent Issued to BioXcel Therapeutics on July 22 for "Non-sedating dexmedetomidine treatment regimens" (Connecticut Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,683, issued on July 22, was assigned to BioXcel Therapeutics Inc. (New Haven, Conn.).

"Non-sedating dexmedetomidine treatment regimens" was invented by Vasukumar Kakumanu (New Haven, Conn.), David Christian Hanley (New Haven, Conn.), Frank Yocca (New Haven, Conn.), Chetan Dalpatbhai Lathia (New Haven, Conn.), Lavanya Rajachandran (New Haven, Conn.) and Robert Risinger (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of administering relatively high doses of dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject, without also inducing significant sedation. The disclosed methods ar...